Stocktoria
Wellgistics Health, Inc. WGRX
Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2025-02-21
Wellgistics Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $23.3M | $18.1M | — |
| Gross profit | -$6.4M | $1.8M | — |
| Operating income | -$93.7M | -$6.1M | -$2.9M |
| Net income | -$101.3M | -$6.9M | -$2.9M |
| EPS (diluted) | $-1.43 | $-0.15 | $-0.06 |
| Operating cash flow | -$10.9M | -$1.2M | -$349,136 |
| Cash & equivalents | $42,571 | $1.0M | $1,364 |
| Inventory | $1.6M | $9.5M | — |
| Total assets | $30.5M | $57.3M | $338,364 |
| Total liabilities | $42.9M | $50.6M | $3.2M |
| Shareholders' equity | -$12.4M | $6.7M | -$2.9M |
Source: SEC EDGAR filings · CIK 0002030763 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.